Louis Larrouquere

Lyon, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases.

Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases.

Journal: Neuro-oncology advances
Published: June 27, 2025

Leptomeningeal disease in breast cancer: State of the art and future directions

Leptomeningeal disease in breast cancer: State of the art and future directions

Journal: Bulletin du cancer
Published: December 17, 2024

ERO1a fosters glioblastoma aggressiveness and metabolic flexibility by regulating mitochondria-associated membrane dynamics.

ERO1a fosters glioblastoma aggressiveness and metabolic flexibility by regulating mitochondria-associated membrane dynamics.

Journal: Nature cell biology
Published: December 12, 2024

Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patients.

Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patients.

Journal: Neuro-oncology advances
Published: December 02, 2024

Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer.

Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer.

Journal: JAMA network open
Published: April 03, 2024

A False-Positive Bone Oligometastatic Prostate Cancer in 18 F-Choline PET/CT : Be Aware of Chronic Vascular Pitfalls.

A False-Positive Bone Oligometastatic Prostate Cancer in 18 F-Choline PET/CT : Be Aware of Chronic Vascular Pitfalls.

Journal: Clinical nuclear medicine
Published: October 05, 2023

Pharmacotherapy for leptomeningeal disease in breast cancer.

Pharmacotherapy for leptomeningeal disease in breast cancer.

Journal: Cancer treatment reviews
Published: September 06, 2023

Discriminating Inflammatory Radiation-Related Changes From Early Recurrence in Patients With Glioblastomas: A Preliminary Analysis of 68 Ga-PSMA-11 PET/CT Compared With 18 F-FDOPA PET/CT.

Discriminating Inflammatory Radiation-Related Changes From Early Recurrence in Patients With Glioblastomas: A Preliminary Analysis of 68 Ga-PSMA-11 PET/CT Compared With 18 F-FDOPA PET/CT.

Journal: Clinical nuclear medicine
Published: June 05, 2023

Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature.

Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature.

Journal: Frontiers in oncology
Published: April 23, 2023

Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.

Identification of a miRNA multi-targeting therapeutic strategy in glioblastoma.

Journal: Cell death & disease
Published: September 12, 2022

Preclinical Evaluation of Sodium Selenite in Mice: Toxicological and Tumor Regression Studies after Striatum Implantation of Human Glioblastoma Stem Cells.

Preclinical Evaluation of Sodium Selenite in Mice: Toxicological and Tumor Regression Studies after Striatum Implantation of Human Glioblastoma Stem Cells.

Journal: International journal of molecular sciences
Published: August 23, 2021

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database.

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database.

Journal: ESMO open
Published: April 05, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026